Back to announcement
20230810_SDPC_Laporan Informasi dan Fakta Material_31360439_lamp1.pdf
Other Text extracted SDPCSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.917
MPI PT MILLENNIUM PHARMACON INTERNATIONAL Tbk No. : 389/MPU/DIR/VIII/2023 Jakarta, 10 Agustus 2023 Lampiran : - Perihal 1 Laporan Informasi atau Fakta Material Yth. Kepala Eksekutif Pengawas Pasar Modal Otoritas Jasa Keuangan Gedung Soemitro Djojohadikusumo Jalan Lapangan Banteng Timur 2-4 Jakarta 10710 Sehubungan dengan Peraturan Otoritas Jasa Keuangan (OJK) no: 31/POJK.04/2015 tanggal 16 Desember 2015 tentang Keterbukaan Informasi atas Fakta Material oleh Emiten atau Perusahaan Publik dan Surat Keputusan Direksi PT Bursa Efek Indonesia No. Kep-00066/BEI/09-2022 tanggal 30 September 2022 perihal Perubahan Peraturan Nomor I-E tentang Kewajiban Penyampaian Informasi, dengan ini kami menyampaikan Laporan Informasi atau Fakta Material sebagai berikut : In reference to Financial Services Authority Regulation No.: 31/POJK.04/2015 dated 16 December 2015 regarding Disclosure of Material Information or Facts by Issuer or Public Company and Decission of the Chairman of the Indonesian Stock Exchange Number Kep-00066/BEV/09-2022 dated 30 September 2022 on Amendment of Regulations No. I-E on Obligation to Information Disclosure, we hereby disclose the information and Material Facts as follow: Nama Emiten atau Perusahaan Publik//ssuer: PT Millennium Pharmacon International Tbk (“Perseroan”) Bidang Usaha/Scope of Business 1 Distribusi produk farmasi, suplemen makanan dan alat kesehatan Telepon/Phone 1 (021)2708 5961, (021) 2708 5964 Faksimili/Facsimile 1 (021) 2708 5958 Alamat surat elektronik/e-mail 1 investor.relation@mpi-pharmaniaga.co.id 1 | Tanggal kejadian Date Event 1 |. 8 Agustus 2023 August 8", 2023 2 | Jenis Informasi atau Fakta Material Type of Information or Material Facts Perolehan Fasilitas Pinjaman Obtaining loan facility 3 | Uraian Informasi atau Fakta Material Description of Information or Material Facts a) Pihak-pihak yang melakukan perjanjian: | a) Parties to the agreement : Company and Perseroan dan PT Bank Central Asia Tbk: PT Bank Central Asia Tbk, b) Bank telah menyetujui memberikan fasilitas | b) The Bank has approved provide a loan pinjaman dengan plafond sejumlah Rp225 Jacilities amounted to IDR225 billion to the Miliar kepada Perseroan, company, c) Jenis Fasilitas : Kredit Multi Fasilitas | c) Type of Facility : Multy-Facility Credit (KMP): d) Jangka waktu fasilitas adalah 1 (satu) tahun, | d) The facility tenor is 1 (one) year. Crown Buni Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia ITRACE Phone : 46221 27085961 Fax : #6221 27085958 ur-Arteri-2-4th-Ftoors MEMBER
Page 2 OCR 0.915
MPI PT MILLENNIUM PHARMACON INTERNATIONAL Tbk 4 | Dampak kejadian, informasi atau fakta | Impact for such information or material fact material tersebut terhada: iatan | towards operational activity, legal, financial operasional, hukum, kondisi keuangan, atau | condition or business continuity of Issuer or | kelangsungan usaha Emiten atau | Public Company | Perusahaan Publik Fasilitas Pinjaman akan menunjang kegiatan | This loan will support Company's business | usaha perseroan. activities. 5 | Keterangan lain-lain Other Information Tidak ada None Hormat kami, PT Millennium Pharmacon International Tbk La INTERNATIONAL Toke Nama: Ahmad bi: Abu Bakar Jabatan: Direktur Ytama Tembusan: PT Bursa Efek Indonesia u.p. Yth. Direksi Crown Bungur Arteri 2-4th Floors Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia Phone : 46221 27085961 Fax : #6221 27085958 INEERMEDIKRS MEMBER
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.